Moreover, results of RASSF1A DNA methylation analysis of urine samples from PCa patients were discussed as potentially useful predictor of biochemical recurrence (combined with pathological staging data) in PCa patients with low Gleason score tumours [27]. This evidence concerns the gene RASSF1 and neoplasm.